A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.


Updates from The Motley Fool

Latest updates on Lexicon Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Lexicon Pharmaceuticals.
Top Biotech Stocks to Buy in 2016

Image source: stevepb via Pixabay. 2015 is shaping up to be another good year for the biotech sec...

This Week in Biotech

With the  SPDR S&P Biotech Index  up 38% over the trailing-12-month period, it's evident that inv...



Stock Performance

View Interactive LXRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Lexicon Pharmaceuticals.
Current Price: $14.98
Prev Close: $14.63
Open: $14.70
Bid: $14.98
Ask: $19.00
Day's Range: $14.33 - $15.04
52wk Range: $7.65 - $19.62
Volume: 715,425
Avg Vol 581,857
Market Cap: $2B
P/E (ttm): -66.50
EPS (ttm): ($0.22)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Lexicon Pharmaceuticals.
CAPS Rating 2 out of 5
 
257 Outperform
46 Underperform
CAPS All Stars
 
49 Outperform
9 Underperform

How do you think Lexicon Pharmaceuticals will perform against the market?



You pick for Lexicon Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Lonnel Coats, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Lexicon Pharmaceuticals.

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers